BioCentury
ARTICLE | Company News

Bind Biosciences board of directors update

September 24, 2012 7:00 AM UTC

Bind Biosciences Inc., Cambridge, Mass. Business: Cancer, Drug delivery Appointed: Daniel Lynch as chairman, formerly CEO and CFO of ImClone Systems Inc., which Eli Lilly and Co. acquired ...